Highland Europe today announces that it has closed its fifth fund, raising €1 billion to double down on its strategy of backing the Continent’s most outstanding founder-led teams in software and internet businesses. David Blyghton, who joined Highland Europe in 2014, is promoted to Partner, a clear indication of Highland Europe’s commitment to nurturing internal talent.
Highland Europe has raised a total of €2.75 billion and has invested in companies such as Adjust, AMCS, Camunda, ContentSquare, Descartes, Deepki, eGym, Featurespace, GetYourGuide, Huel, Jellysmack, Malwarebytes, MatchesFashion, Me+Em, Nexthink, Podimo, Spot, Supermetrics, WeTransfer, Wolt and Zwift.
Fergal Mullen, Partner, said: “We want to thank all of those European founders who chose to partner with us over the past ten years. It is their ambition, talent and drive that inspires us as we build category-defining businesses together. Current market conditions are not easy, but our founder-led companies continue to scale impressively and efficiently, with several world-leaders in the mix. We’re pleased that our investors share our conviction and thank them for their continued trust.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005315/en/
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ESI-GROUP23.3.2023 08:01:29 CET | Press release
ESI Group Reveals Bold Rebranding to Celebrate 50 Years and Marks the Beginning of a Next Chapter
KIRIN-HOLDINGS23.3.2023 06:01:35 CET | Press release
Norges Bank Terminates Its Observation On Kirin Holdings
MA-ADVENT-TECHNOLOGIES23.3.2023 01:26:33 CET | Press release
Hyundai Motor Company and Advent Technologies Sign Joint Development Agreement Following Successful Fuel Cell Technology Assessment
PA-BENTLEY/WORLDSENSING22.3.2023 21:02:32 CET | Press release
Bentley Systems Announces Strategic Agreement with Worldsensing
DE-INCYTE22.3.2023 18:15:25 CET | Press release
Incyte Announces FDA Approval of Zynyz™ (retifanlimab-dlwr) for the Treatment of Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma (MCC)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom